stem cells Archives - Market Exclusive

Home Tags Stem cells

Skin & Bones of Regenerative Medicine Takes A Leap Forward With...

David Rich - February 14, 2017

Pluristem Therapeutics Inc. (NASDSAQ:PSTI) To Begin CLI Phase III Trial Enrolling...

David Rich - January 11, 2017

Caladrius Biosciences Inc (NASDAQ:CLBS) Way Oversold As 2016 Comes to a...

ME Contributor - January 3, 2017

Why Pluristem Therapeutics Inc. Is So Undervalued – The Market Is...

Rafi Farber - November 3, 2016

Pluristem Therapeutics Inc. (NASDAQ:PSTI) Gears Up For Critical Blood Stem Cell...

David Rich - September 19, 2016

Will Pluristem Therapeutics Inc. (NASDAQ:PSTI) Succeed in CLI Where Sanofi SA...

David Rich - August 11, 2016

Japan is Breathing Life into the Stem Cell Space, Astellas Pharma...

ME Contributor - July 21, 2016

Have Markets Misinterpreted bluebird bio Inc’s (NASDAQ:BLUE) Latest Interim Update?

Roger Hannington - April 21, 2016

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Could Change the Face of Stem Cell...

ME Staff - April 14, 2016

Is Bellicum A Worthy Index/Portfolio Addition?

Jennifer Aldershot - December 21, 2015

/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup April 15

April 15, 2019

Canopy Growth Spectrum Cannabis Targets Canadians Seniors

April 15, 2019

Cannabis Stock News Daily Roundup April 12

April 12, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: stem cells